Wells Fargo lowered the firm’s price target on Arvinas to $60 from $63 and keeps an Overweight rating on the shares. The firm believes management reiterating timelines for vepdeg’s VERITAC-2’s second half of 2024 read out is a positive and potential for vepdeg combo data should abate fears about combinability.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARVN:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue